Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Oseltamivir+Zanamivir"'
Autor:
Akemi Koike, Naoko Koseki, Akihito Ishizaka, Yoshio Hatae, Hideaki Kikuta, Akiko Okamura, Katsuki Azuma, Naoko Nagano, Mutsuko Konno, Kohichi Yasoshima, Mari Murashita, Hideto Furuyama, Yoshihiro Kumita, Keisuke Morita, Kyosuke Hazama, Hayato Aoyagi, Keiji Tsubakihara, Kimihiko Takada, Tadashi Ariga, Chie Tobise, Miki Kaiho, Nobuhisa Ishiguro, Akira Tsuchiyama, Takehiro Togashi, Koji Oba, Hideki Arioka, Kazuyuki Uetsuji, Yoko Sawada, Yoshihiro Matsuzono, Kazue Yasuda, Mutsuo Shibata, Shigeru Yamazaki, Yasushi Akutsu, Toru Watanabe, Satoru Shida, Mikio Yoshioka, Tatsuru Yamanaka, Yuuichi Tabata, Akira Inagawa, Nobuaki Kawamura, Akira Tsuchida, Yasuhisa Odagawa
Publikováno v:
Journal of Infection and Chemotherapy. 24:449-457
The clinical effectiveness of four neuraminidase inhibitors (NAIs) (oseltamivir, zanamivir, laninamivir, and peramivir) for children aged 0 months to 18 years with influenza A and B were investigated in the 2014-2015 to 2016-2017 influenza seasons in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f36075ef572505e0743b86240567a82
https://doi.org/10.1016/j.jiac.2018.01.013
https://doi.org/10.1016/j.jiac.2018.01.013
Publikováno v:
Antiviral Research. 105:54-58
The efficacy of oseltamivir-zanamivir combination therapy compared to that of monotherapy was evaluated in mice infected with influenza A(H3N2) or A(H1N1)pdm09 viruses. For A(H3N2) virus, zanamivir monotherapy and oseltamivir-zanamivir combination sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b71caaa45d01959ad0a628aef44c6cb
https://doi.org/10.1016/j.antiviral.2014.02.017
https://doi.org/10.1016/j.antiviral.2014.02.017
Autor:
Vladimir Frecer, Thanyarat Udommaneethanakit, Thanyada Rungrotmongkol, Urban Bren, Miertus Stanislav
Publikováno v:
Journal of Chemical Information and Modeling. 49:2323-2332
The outbreak of avian influenza A subtype H5N1 virus has raised a global concern for both animal as well as human health. Recently, drug resistance in H5N1 infections has been widely reported due to neuraminidase mutations. Consequently, the understa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e48449c856ec5545691cc2d2ec0b048
https://doi.org/10.1021/ci900277r
https://doi.org/10.1021/ci900277r
Autor:
Chen-hsiung Chan, Yeng-Tseng Wang
Publikováno v:
2010 International Conference on Bioinformatics and Biomedical Technology.
The neuraminidase of the influenza virus is the target of the anti-flu drugs oseltamivir and zanamivir. Clinical practices show that zanamivir and oseltamivir are effective to treat the 2009 H1N1 influenza virus. Herein, we report the findings of mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fbf1e391f2cafa82e78ac1b3bcfd3aa
https://doi.org/10.1109/icbbt.2010.5479022
https://doi.org/10.1109/icbbt.2010.5479022
Autor:
Elizabeth Mechcatie
Publikováno v:
Family Practice News. 37:4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a8394c19286a8b62eac0260f7cf7eab
https://doi.org/10.1016/s0300-7073(07)71445-7
https://doi.org/10.1016/s0300-7073(07)71445-7